(1)
EVALUATION THE INFLUENCE OF LIPOPROTEIN LIPASE GENE POLYMORPHISM ON ROSUVASTATIN TREATMENT OUTCOME IN PATIENTS WITH CORONARY ARTERY DISEASE IN AL NAJAF GOVERNORATE. RJDNMD 2024, 31 (1), 543-556.